President Donald Trump’s state visit to the UK has delivered pledges from US tech giants to invest a combined $42 billion to ...

British pharmaceutical giant GlaxoSmithKline (GSK) has announced a massive $30 billion investment in the United States. The ...

The facility will be located on a 227-acre site that's currently owned by Henrico-based insurance company Markel and at least ...

GSK has become the latest pharma giant to direct investment away from the UK as it unveiled a new plan to spend $30bn (£22bn) ...

Elli Lilly has chosen a location near Richmond, VA, for its planned $5 billion manufacturing plant that will be the first-ever dedicated, fully integrated active pharmaceutical ingredient (API) and ...

Germany-headquartered technology giant Merck has set its sights on becoming the "best partner of choice" in the ...

GSK, led by boss Emma Walmsley (pictured), said it would invest $30bn in R&D and supply chain infrastructure over the next ...

Pharmaceutical giant Eli Lilly expanded its Virginia facility investment plans to $5 billion from original $2.1 billion amid ...

Merck offers a compelling opportunity for long-term income and value investors, trading near its 52-week low with a 4% dividend yield. Learn more about MRK stock here.